ProFoundTx
@ProFoundTx
Followers
128
Following
8
Statuses
75
Pioneering the expanded human proteome to reveal a universe of new medicines.
Joined March 2022
On the International Day of Women and Girls in Science, we honor the women shaping the future of healthcare through innovation and dedication. Members of the ProFound team shared advice for aspiring #WomenInScience. Learn more about our team: #February11
7
0
1
Scientists at ProFound and beyond are uncovering the hidden universe of 'dark proteins'—overlooked proteins that could play key roles in human disease. These discoveries expand the horizon for #DrugDevelopment, and we’re excited about their potential. Read more in @Nature:
“The leaders of the Human Genome Project always knew they were just starting a conversation” The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out what they do
0
0
1
Our CEO, John Lepore, MD, shared the latest on the ProFoundry platform, thoughts on how the company is prioritizing targets that have the potential to become meaningful medicines & plans for the year ahead in a CEO Chat with @FlagshipPioneer: #JPM25
0
0
3
As Noubar Afeyan shared in @FlagshipPioneer’s annual letter, “we founded ProFound Therapeutics to interrogate what was once deemed ‘junk,’ revealing a vastly expanded human proteome that includes thousands of previously undiscovered proteins.” Access the letter at the link below.
Read or listen to Flagship Pioneering’s 2025 Annual Letter in which Founder & CEO @NoubarAfeyan explores polyintelligence — the synthesis of human, machine, and nature's intelligence, and how it is driving a new renaissance in science and technology: Drawing inspiration from Leonardo da Vinci's integrated thinking, Noubar discusses how artificial intelligence will enhance our understanding of nature's adaptive genius in unprecedented ways. He highlights breakthroughs in biotechnology, agriculture, and machine intelligence, and how these polyintelligent innovations can tackle multifaceted challenges in health, climate, and beyond. And for more on how polyintelligence is informing and guiding Flagship’s work, dive into our newly launched Special Section: #BiggerLeaps #FlagshipStudio #JPM25
0
0
4
#HappyHolidays from all of us at ProFound Therapeutics! We look forward to spending this time reflecting on the personal and professional accomplishments from the last year and cherishing moments with loved ones. Wishing everyone a joyful and restful holiday season!
0
0
4
2024 was a year of significant milestones for us at ProFound. We’re grateful for our dedicated team members and valued partners for making these accomplishments possible. Here’s to a bright and innovative year ahead!
0
0
2
Harnessing insights from our ever-expanding database, we leverage our ProFoundry™ Atlas to predict the function & therapeutic relevance of new proteins we uncover within the #ExpandedProteome. Learn how we are unlocking a new universe of possibilities:
0
0
1
🎉 Exciting news! We’re thrilled to announce that we have been recognized as a 2025 @BioSpace Best Places to Work. A huge thank you to our incredibly talented and dedicated team for making this achievement possible. Together, we’re shaping the future for patients. #ProFoundPeople
0
0
2
We had an amazing time at the @BosBizJournal #40Under40 ceremony, celebrating our very own @vinidhra as one of Boston's rising leaders making a real impact. Congratulations, Vini, on this incredible accomplishment!
0
0
3
Our industrialized application of RiboSeq technology at scale identifies proteins actively being translated by the ribosome by taking a snapshot of #RNA translation, discovering novel proteins in primary human tissues quickly, accurately. More:
0
0
1
Next week, our CEO, John Lepore, will be moderating a panel at the @LongwoodLeaders #BostonCEO meeting. Stop by the panel to hear insights from industry experts on accelerating the translation of science into medicine. More details about the panel here:
0
1
2
At ProFound, we're a team of pioneers dedicated to our #ProFoundPurpose of illuminating the #ExpandedProteome to unlock new therapeutic possibilities for patients. Visit our careers page for open opportunities to make a profound impact on human health:
0
0
0
Check out this recent interview featuring our CEO, John Lepore with @brandloncar of @BiotechTVHQ discussing how we're exploring the #ExpandedProteome to unveil new drugs and drug targets to develop potential first-in-class medicines for patients.
𝐓𝐚𝐥𝐤𝐢𝐧𝐠 𝐒𝐜𝐢𝐞𝐧𝐜𝐞: Flagship's @ProFoundTx is searching for proteins for use as therapeutics and targets beyond those found in the traditional protein coding regions of DNA. Full video:
0
0
2
Had a fun night celebrating our #Fierce15 win at the @FierceBiotech awards ceremony! We’re proud of our team’s accomplishments to date & are excited about what lies ahead as we pioneer the #ExpandedProteome & advance our #ProFoundPurpose of bringing new therapies to patients.
0
0
1
Next week, our CEO, John Lepore, is joining a panel at the @MBGInnovation World Medical Innovation Forum. Stop by to learn about new innovations being developed to address the many patient needs that remain unmet. #WMIF2024
0
1
2
📆 Mark your calendars! Our CEO, John Lepore, is moderating a panel at the @BioCentury Grand Rounds R&D conference. Listen in on the discussion to learn about the role of causal #biology in achieving preclinical validation. More: #BioCenturyGrandRounds
0
0
4
Our Chief Innovation Officer @vinidhra has been named a 2024 @BosBizJournal 40 under 40 honoree! Vini’s leadership & contributions since our founding have been invaluable to our rapid growth & success illuminating the #ExpandedProteome. See the full list:
0
1
7
Want to learn about proteins hidden within our genome? Cast your vote for “The Secret Life of DNA” panel @SXSW 2025, diving into the mysteries of DNA & how new genetic knowledge is the future of medicine. #PanelPicker voting is open until August 18th:
0
0
2
We’re thrilled to announce @FierceBiotech has selected us as a 2024 #Fierce15 #biotech company! This year we have rapidly advanced our ProFoundry™ Platform identifying novel proteins with the possibility to bring new therapeutic options to patients. More:
0
1
7
In the latest episode of the @BioProcessOL #BusinessOfBiotech podcast, our CEO, John Lepore, dives into our mission of pioneering the #ExpandedProteome and bringing new therapeutic possibilities to patients worldwide. Listen to the episode here:
0
0
6